Journal of the Pancreas Open Access

Any Second-Line Therapy for Advanced Pancreatic Cancer? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Jia Li, Muhammad Wasif Saif, Man Yee Merl

Autoimmune Pancreatitis: An Autonomous Disease or a Single Entity in a Complex Puzzle of a Multi-Organ Disorder?

• Generoso Uomo

Pulmonary Toxicity Associated with Gemcitabine

• Muhammad Wasif Saif

Gemcitabine-Induced Pulmonary Toxicity in a Patient with Pancreatic Cancer

• Daigo Hiraya, Katsunori Kagohashi, Naoya Sakamoto, Tadashi Kondo, Hiroaki Satoh

Improvements in Care in Acute Pancreatitis by the Adoption of an Acute Pancreatitis Algorithm

• Karen R Cox, Laurel Despins, Les W Hall, Matthew L Bechtold, Jack D Bragg

Management of Skin Toxicities of Anti-EGFR Agents in Patients with Pancreatic Cancer and Other GI Tumors by Using Electronic Communication: Effective and Convenient

• Kristin Kaley, Muhammad Wasif Saif, Lynne Lamb, Jennifer Pecerillo, Susan Hotchkiss , Lisa Steven, Marianne Brennan, Robin Penney, Carolyn Gillespie, Walid Shaib

Malignant Melanoma Presenting as Obstructive Jaundice Secondary to Metastasis to the Ampulla of Vater

• Joshua A Marks, Atul S Rao, David Loren, Agnes Witkiewicz, Michael J Mastrangelo, Adam C Berger

Lymphoepithelial Pancreatic Cyst: An Atypical Benign Pancreatic Mass Presenting with a “Cheerios-Like” Appearance

• Simone Maurea, Alessia Matrone, Maria Russo, Carmine Mollica, Domenico Lombardi, Guido Lombardi, Massimo Imbriaco

EUS-Guided Pancreatic Cyst Brushing: A Comparative Study in a Tertiary Referral Centre

• Titus Thomas, James Bebb, Jayan Mannath, Krish Ragunath, Guruprasad P Aithal, Phillip V Kaye

Oral Pancreatic Enzyme Substitution Therapy in Chronic Pancreatitis: Is Clinical Response an Appropriate Marker for Evaluation of Therapeutic Efficacy?

• J Enrique Dom?nguez-Mu?oz, Julio Iglesias-Garc?a

Palliative Care from the Beginning of Treatment for Advanced Pancreatic Cancer Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, James Mark Lazenby

Chronic Asymptomatic Pancreatic Hyperenzymemia: Is It a Benign Anomaly or a Disease?

• Alberto Mariani

The First-Line Treatment for Advanced Pancreatic Cancer Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Jia Li, Muhammad Wasif Saif, Man Yee Merl

Updates in Adjuvant Therapy in Pancreatic Cancer: Gemcitabine and Beyond Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, Joshua Richter

Locally Advanced Pancreatic Adenocarcinoma: Where Are We and Where Are We Going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, Joshua Richter

Neuroendocrine Tumors of the Pancreas: What's New Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, Konstantinos N Syrigos, Anastasios T Dimou

Intraductal Papillary Mucinous Neoplasia (IPMN) Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, Scott Bussom

Methods and Rationale for the Early Detection of Pancreatic Cancer Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Muhammad Wasif Saif, Scott Bussom

Translational Research in Pancreatic Cancer Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010

• Konstantinos N Syrigos, Muhammad Wasif Saif, Alexios S Strimpakos

Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer

• Ioannis Gounaris, Kamarul Zaki, Pippa Corrie

Micronutrient Therapy for Chronic Pancreatitis: Rationale and Impact

• Joan M Braganza, Thomas L Dormandy